Stargardt Disease Clinical Trials in Portland, Oregon

4 studies are recruiting for stargardt disease in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

    Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular dystrophies, some of the cells in the macula gradually stop working and may die over time. This lead…

    Stage
    Not phased
    Ages
    6 and older
    Site
    Casey Eye Institute - Oregon Health & Science University, Portland, Oregon
    Locations
    15 in total
    Run by
    Astellas Pharma Global Development, Inc.

    See if you can join NCT07425574 on ClinicalTrials.gov

  2. Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

    This study is an open-label, single ascending dose clinical trial in participants who have ABCA4-related retinopathies. This is the first-in-human clinical trial in which ACDN-01 will be evaluated for safety, tolerability, and preliminary efficacy following a single subretinal injection of ACDN-01.

    Stage
    Phase 1
    Ages
    12 and older
    Site
    Casey Eye Institute OHSU, Portland, Oregon
    Locations
    10 in total
    Run by
    Ascidian Therapeutics, Inc

    See if you can join NCT06467344 on ClinicalTrials.gov

  3. An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

    This is an Observational Study to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene This is a multicenter study which will enroll approximately 75 subjects

    Stage
    Not phased
    Ages
    12 to 65
    Site
    Oregon Health & Science University, Portland, Oregon
    Locations
    20 in total
    Run by
    Splice Bio

    See if you can join NCT06435000 on ClinicalTrials.gov

  4. A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

    This Phase 1/2 study will evaluate the safety, tolerability, and preliminary efficacy of subretinal SB-007 administration to determine dose selection in subjects with Stargardt's Type 1 (STGD1). This is a multicenter study which will enroll approximately 57 subjects, followed up over a 96 week peri…

    Stage
    Phase 1
    Ages
    12 to 65
    Site
    Oregon Health & Science University, Portland, Oregon
    Locations
    5 in total
    Run by
    Splice Bio

    See if you can join NCT06942572 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.